Sema4A inhibits the therapeutic effect of IFN-β in EAE. Koda T, Okuno T, Takata K, Honorat J A, Kinoshita M, Tada S, Moriya M, Sakoda S, Mochizuki H, Kumanogoh A, et al. J Neuroimmunol. 2014 Jan 7. PMID: 24439904. Abstract CommentRecommendBookmarkWatch